A new level of collaboration is needed to overcome the current and future challenges facing healthcare globally, according to international research presented recently.
Paul Tunnah spoke to Jane Griffiths, company group chairman, Janssen pharma companies (Johnson & Johnson) EMEA, at the recent eyeforpharma Barcelona event about some of the big questions fa
New technologies and new business models are transforming life science companies. A new book from Accenture maps out the fresh approaches being taken across healthcare.
Andrew McConaghie reviews the findings of the latest pharma ranking index, which assesses on the premise: if you gave the same molecule to two different companies in early phase, which would ma